Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study
Article in Orphanet Journal of Rare Diseases (October 2023)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Article in Orphanet Journal of Rare Diseases (October 2023)
Article in Cureus (April 2023)
Article in Medicine (September 2022)